EverCommerce, Inc. EVCM 深 沪
等待开盘 04-01 09:30:00 美东时间
11.43
-0.350
-2.97%
华盛通- 最 高11.95
- 今 开11.95
- 成交量 14.90万股
- 最 低 11.325
- 昨 收 11.78
- 总市值 20.30亿
- 52周最高 14.41
- 市盈率 静 112.39
- 换手率 0.08%
- 52周最低 7.66
- 委 比 -12.41%
- 总股本 1.78亿
- 历史最高 23.41
- 量 比 0.94
- 振 幅 5.31%
- 历史最低 5.87
- 每 手 1
- 风险率 1.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
Goldman Sachs Maintains Sell on EverCommerce, Lowers Price Target to $8
Goldman Sachs analyst Gabriela Borges maintains EverCommerce (NASDAQ:EVCM) with a Sell and lowers the price target from $9 to $8.
03-14 01:55
Citizens Downgrades EverCommerce to Market Perform
Citizens analyst Aaron Kimson downgrades EverCommerce (NASDAQ:EVCM) from Market Outperform to Market Perform.
03-13 18:32
12 Information Technology Stocks Moving In Thursday's After-Market Session
Gainers Silvaco Group (NASDAQ:SVCO) stock rose 14.1% to $3.77 during Thursday'...
03-13 05:05
EverCommerce shares are trading lower after the company reported Q4 financial results and issued Q1 sales guidance below estimates.
EverCommerce shares are trading lower after the company reported Q4 financial r...
03-13 04:28
EverCommerce Sees Q1 Sales $145.500M-$148.500M vs $151.150M Est
EverCommerce (NASDAQ:EVCM) sees Q1 sales of $145.500 million-$148.500 million vs $151.150 million analyst estimate.
03-13 04:09
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
Shares of software companies are trading lower after Citrini Research flagged risks AI could pose to the global economy. The move comes alongside broader market weakness, adding pressure to the sector.
Shares of software companies are trading lower after Citrini Research flagged r...
02-24 04:26
美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
RBC Capital Downgrades EverCommerce to Sector Perform, Maintains Price Target to $12
RBC Capital analyst Matthew Hedberg downgrades EverCommerce (NASDAQ:EVCM) from Outperform to Sector Perform and maintains the price target from $12 to $12.
01-06 00:37
